MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$166,131
Net Income
-$6,283,786
Net Profit Margin
-3782.43%
EPS
-$1.46
Unit: Dollar
Revenue Breakdown
total revenue-us-US
total revenue-non us-Non Us
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
total revenue
166,131
145,954
263,922
145,380
Cost of revenue
45,303
193,768
142,396
26,285
Gross profit
120,828
-47,814
121,526
119,095
Sales and marketing
466,681
467,955
545,451
568,937
General and administrative
1,500,803
2,503,126
1,869,207
1,815,945
Research and development
4,152,287
5,934,071
5,099,086
4,480,678
Depreciation and amortization
201,840
255,445
267,566
267,383
Impairment charges
-
-
18,882,000
-
Total operating expenses
6,321,611
9,160,597
26,663,310
7,132,943
Loss from operations
-6,200,783
-9,208,411
-26,541,784
-7,013,848
Interest income, net
17,493
6,974
253,979
13,194
Realized gain on investments
-
-
0
41,542
Gain (loss) on disposition of assets
-
-
-74,915*
4,000
Gain (loss) on remeasurement of acquisition contingencies
-29,171
75,280
118,417*
-42,345
Gain on equity method investment in joint ventures
-52,157
-13,361
24,862
-55,959
Total other income (expense), net
-63,835
68,893
322,343
-39,568
Loss before income taxes
-6,264,618
-9,139,518
-26,219,441
-7,053,416
Income tax provision
19,168
520
-473,716
-1,166,593
Net loss
-6,283,786
-9,140,038
-25,745,725
-5,886,823
Change in net unrealized gains (losses) on marketable securities, net of tax
-
-
-94,888
-39,180
Total other comprehensive income (loss)
-
-
-94,888
-39,180
Comprehensive loss
-6,283,786
-9,140,038
-25,840,613
-5,926,003
Basic EPS
-1.46
-4.06
0.264
-0.16
Diluted EPS
-1.46
-4.06
0.264
-0.16
Basic Average Shares
4,309,997
2,253,474
-97,727,475
37,890,923
Diluted Average Shares
4,309,997
2,253,474
-97,727,475
37,890,923
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$6,283,786
(20.73%↑ Y/Y)
Revenue From Contract
With Customer...
$105,386
Revenue From Contract
With Customer...
$60,745
(-62.71%↓ Y/Y)
Net loss
-$6,283,786
(18.71%↑ Y/Y)
total revenue-us-US
$105,386
total revenue-non
us-Non Us
$60,745
Loss before income
taxes
-$6,264,618
(18.83%↑ Y/Y)
Income tax provision
$19,168
(55.50%↑ Y/Y)
total revenue
$166,131
(1.98%↑ Y/Y)
Loss from operations
-$6,200,783
(23.05%↑ Y/Y)
Total other income
(expense), net
-$63,835
(-118.78%↓ Y/Y)
Gross profit
$120,828
(-7.63%↓ Y/Y)
Interest income, net
$17,493
(43.88%↑ Y/Y)
Cost of revenue
$45,303
(41.10%↑ Y/Y)
Total operating
expenses
$6,321,611
(-22.80%↓ Y/Y)
Gain on equity method
investment in joint...
-$52,157
(-279.05%↓ Y/Y)
Gain (loss) on
remeasurement of acquisition...
-$29,171
(-385.37%↓ Y/Y)
Research and development
$4,152,287
(-11.42%↓ Y/Y)
General and
administrative
$1,500,803
(-42.28%↓ Y/Y)
Sales and marketing
$466,681
(-23.46%↓ Y/Y)
Depreciation and
amortization
$201,840
(-30.74%↓ Y/Y)
Buy us a coffee
Co-Diagnostics, Inc. (CODX)
Co-Diagnostics, Inc. (CODX)